These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15958276)

  • 21. Nerve growth factor prevents demyelination, cell death and progression of the disease in experimental allergic encephalomyelitis.
    Parvaneh Tafreshi A
    Iran J Allergy Asthma Immunol; 2006 Dec; 5(4):177-81. PubMed ID: 17237570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A potential role for estrogen in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Offner H; Polanczyk M
    Ann N Y Acad Sci; 2006 Nov; 1089():343-72. PubMed ID: 17261780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lessons from multiple sclerosis: models, concepts, observations.
    Wekerle H
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii56-60. PubMed ID: 19022815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis.
    Steinman L; Zamvil SS
    Trends Immunol; 2005 Nov; 26(11):565-71. PubMed ID: 16153891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Permanent effector phenotype of neuroantigen-specific T cells acquired in the central nervous system during experimental allergic encephalomyelitis.
    Hofstetter HH; Toyka KV; Gold R
    Neurosci Lett; 2006 Jan; 391(3):127-30. PubMed ID: 16198481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment with rapamycin ameliorates clinical and histological signs of protracted relapsing experimental allergic encephalomyelitis in Dark Agouti rats and induces expansion of peripheral CD4+CD25+Foxp3+ regulatory T cells.
    Donia M; Mangano K; Amoroso A; Mazzarino MC; Imbesi R; Castrogiovanni P; Coco M; Meroni P; Nicoletti F
    J Autoimmun; 2009 Sep; 33(2):135-40. PubMed ID: 19625166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple sclerosis: human model for EAE?
    Hohlfeld R
    Eur J Immunol; 2009 Aug; 39(8):2036-9. PubMed ID: 19672899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neural precursors attenuate autoimmune encephalomyelitis by peripheral immunosuppression.
    Einstein O; Fainstein N; Vaknin I; Mizrachi-Kol R; Reihartz E; Grigoriadis N; Lavon I; Baniyash M; Lassmann H; Ben-Hur T
    Ann Neurol; 2007 Mar; 61(3):209-18. PubMed ID: 17187374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minocycline effects on the cerebrospinal fluid proteome of experimental autoimmune encephalomyelitis rats.
    Stoop MP; Rosenling T; Attali A; Meesters RJ; Stingl C; Dekker LJ; van Aken H; Suidgeest E; Hintzen RQ; Tuinstra T; van Gool A; Luider TM; Bischoff R
    J Proteome Res; 2012 Aug; 11(8):4315-25. PubMed ID: 22768796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A chimeric TCR-beta chain confers increased susceptibility to EAE.
    Petersen TR; Lata R; Spittle E; Bäckström BT
    Mol Immunol; 2007 Jul; 44(14):3473-81. PubMed ID: 17481734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental models of neuroprotection relevant to multiple sclerosis.
    Yong VW; Giuliani F; Xue M; Bar-Or A; Metz LM
    Neurology; 2007 May; 68(22 Suppl 3):S32-7; discussion S43-54. PubMed ID: 17548566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploiting genotypic differences to identify genes important for EAE development.
    Jelinsky SA; Miyashiro JS; Saraf KA; Tunkey C; Reddy P; Newcombe J; Oestreicher JL; Brown E; Trepicchio WL; Leonard JP; Marusic S
    J Neurol Sci; 2005 Dec; 239(1):81-93. PubMed ID: 16214174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon β-secreting mesenchymal stem cells combined with minocycline attenuate experimental autoimmune encephalomyelitis.
    Hou Y; Heon Ryu C; Jun JA; Kim SM; Jeong CH; Jeun SS
    J Neuroimmunol; 2014 Sep; 274(1-2):20-7. PubMed ID: 25005115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early MRI changes in a mouse model of multiple sclerosis are predictive of severe inflammatory tissue damage.
    Nessler S; Boretius S; Stadelmann C; Bittner A; Merkler D; Hartung HP; Michaelis T; Brück W; Frahm J; Sommer N; Hemmer B
    Brain; 2007 Aug; 130(Pt 8):2186-98. PubMed ID: 17617655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amelioration of acute and relapsing stages of the experimental allergic encephalomyelitis by cobra toxins.
    Mohamed A; Reid PF; Raymond L; Dufan T
    Biomed Sci Instrum; 2006; 42():399-404. PubMed ID: 16817641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Possible role of ependymal proliferation in improving experimental allergic encephalomyelitis in Lewis rats.
    Mohamed A; Yunus M; Hamadain E; Benghuzzi H
    Biomed Sci Instrum; 2006; 42():405-9. PubMed ID: 16817642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of Multiple Sclerosis candidate gene expression kinetics in rat experimental autoimmune encephalomyelitis.
    Thessen Hedreul M; Gillett A; Olsson T; Jagodic M; Harris RA
    J Neuroimmunol; 2009 May; 210(1-2):30-9. PubMed ID: 19269041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients.
    Ruggieri M; Pica C; Lia A; Zimatore GB; Modesto M; Di Liddo E; Specchio LM; Livrea P; Trojano M; Avolio C
    J Neuroimmunol; 2008 Jul; 197(2):140-6. PubMed ID: 18555539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Innate immunity modulates autoimmunity: type 1 interferon-beta treatment in multiple sclerosis promotes growth and function of regulatory invariant natural killer T cells through dendritic cell maturation.
    Gigli G; Caielli S; Cutuli D; Falcone M
    Immunology; 2007 Nov; 122(3):409-17. PubMed ID: 17617156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Congruent effects of estrogen and T-cell receptor peptide therapy on regulatory T cells in EAE and MS.
    Offner H; Vandenbark AA
    Int Rev Immunol; 2005; 24(5-6):447-77. PubMed ID: 16318990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.